Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Aug;77(2):257–262.

Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.

L Sirota 1, B Kupfer 1, C Moroz 1
PMCID: PMC1541995  PMID: 2528432

Abstract

CM-H-9 monoclonal antibody specific for placental isoferritin (PLF) was used to quantify PLF in the serum and on peripheral blood lymphocytes derived from term delivery women and healthy controls. It was found that the mean level of PLF in maternal sera was 50.4 +/- 50.1 U/ml, whereas in normal adults the mean serum PLF level was very low (4.5 +/- 7.7 U/ml). Furthermore, term mothers exhibited a sub-population of peripheral blood lymphocytes (PBL) which stained positively with CM-H-9 MoAb (mean 11.6 +/- 7.8%). Such lymphocytes were scarce in normal non-pregnant women (mean 0.8 +/- 1.2%). The effect of PLF on lymphocyte transformation in MLC was studied in mixed lymphocyte cultures of maternal-newborn and normal non-related PBL controls. It was found that placental isoferritin was immunosuppressive in comparison to normal adult ferritin. The suppressive effect was significantly higher in maternal-newborn MLC compared to normal adult controls. Furthermore, it was found that PLF which is present in maternal serum has an immunosuppressive activity since, its removal on CM-H-9 MoAb affinity column abrogated this effect. The results of this study suggest that both PLF and PLF binding lymphocytes play a role in the development of immunosuppression during pregnancy. Therefore the lack of one of the factors may result in diminished immunosuppression or in fetal rejection.

Full text

PDF
257

Images in this article

259Fig. 1
on p.259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bessler H., Sirota L., Dulitzky F., Djaldetti M. Cord serum inhibits allogeneic mixed lymphocyte reaction and stimulates lymphokine production. J Reprod Immunol. 1986 Jul;9(2):103–110. doi: 10.1016/0165-0378(86)90004-5. [DOI] [PubMed] [Google Scholar]
  2. Bessler H., Sirota L., Dulitzky F., Djaldetti M. Production of interleukin-1 by mononuclear cells of newborns and their mothers. Clin Exp Immunol. 1987 Jun;68(3):655–661. [PMC free article] [PubMed] [Google Scholar]
  3. Ceppellini R., Bonnard G. D., Coppo F., Miggiano V. C., Pospisil M., Curtoni E. S., Pellegrino M. Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant Proc. 1971 Mar;3(1):58–63. [PubMed] [Google Scholar]
  4. Digitalis and arrhythmias. N Engl J Med. 1977 May 19;296(20):1175–1176. doi: 10.1056/NEJM197705192962021. [DOI] [PubMed] [Google Scholar]
  5. Drysdale J. W. Microheterogeneity in ferritin molecules. Biochim Biophys Acta. 1970 Apr 28;207(1):256–258. doi: 10.1016/0005-2795(70)90158-3. [DOI] [PubMed] [Google Scholar]
  6. Han T. Human chorionic gonadotropin. Its inhibitory effect on cell-mediated immunity in vivo and in vitro. Immunology. 1975 Sep;29(3):509–515. [PMC free article] [PubMed] [Google Scholar]
  7. Hancock B. W., Bruce L., May K., Richmond J. Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma. Br J Haematol. 1979 Oct;43(2):223–233. doi: 10.1111/j.1365-2141.1979.tb03745.x. [DOI] [PubMed] [Google Scholar]
  8. Hellström K. E., Hellström I., Brawn J. Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature. 1969 Nov 29;224(5222):914–915. doi: 10.1038/224914a0. [DOI] [PubMed] [Google Scholar]
  9. KALISS N., DAGG M. K. IMMUNE RESPONSE ENGENDERED IN MICE BY MULTIPARITY. Transplantation. 1964 May;2:416–425. doi: 10.1097/00007890-196405000-00011. [DOI] [PubMed] [Google Scholar]
  10. Levo Y., Rotter V., Ramot B. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease. Biomedicine. 1975 Jun 30;23(6):198–200. [PubMed] [Google Scholar]
  11. Matzner Y., Konijn A. M., Shlomai Z., Ben-Bassat H. Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function. Br J Haematol. 1985 Mar;59(3):443–448. doi: 10.1111/j.1365-2141.1985.tb07331.x. [DOI] [PubMed] [Google Scholar]
  12. Moroz C., Bessler H., Lurie Y., Shaklai M. New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies. Exp Hematol. 1987 Mar;15(3):258–262. [PubMed] [Google Scholar]
  13. Moroz C., Bessler H., Sirota L., Dulitzky F., Djaldetti M. Difference in the placental ferritin levels measured by a specific monoclonal antibody enzymoassay in preterm and term delivery. Clin Exp Immunol. 1987 Sep;69(3):702–706. [PMC free article] [PubMed] [Google Scholar]
  14. Moroz C., Kupfer B. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer. Isr J Med Sci. 1981 Sep-Oct;17(9-10):879–881. [PubMed] [Google Scholar]
  15. Moroz C., Kupfer B., Twig S., Parhami-Seren B. Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chim Acta. 1985 May 30;148(2):111–118. doi: 10.1016/0009-8981(85)90220-7. [DOI] [PubMed] [Google Scholar]
  16. Moroz C., Lahat N., Biniaminov M., Ramot B. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole. Clin Exp Immunol. 1977 Jul;29(1):30–35. [PMC free article] [PubMed] [Google Scholar]
  17. Moroz C., Misrock S. L., Siegal F. P. Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS. AIDS. 1989 Jan;3(1):11–16. [PubMed] [Google Scholar]
  18. Murgita R. A. The immunosuppressive role of alpha-fetoprotein during pregnancy. Scand J Immunol. 1976;5(9):1003–1014. doi: 10.1111/j.1365-3083.1976.tb03052.x. [DOI] [PubMed] [Google Scholar]
  19. Murgita R. A., Wigzell H. The effects of mouse alpha-fetoprotein on T-cell-dependent and T-cell-independent immune responses in vitro. Scand J Immunol. 1976;5(10):1215–1220. doi: 10.1111/j.1365-3083.1976.tb00265.x. [DOI] [PubMed] [Google Scholar]
  20. Nicholas N. S., Panayi G. S., Nouri A. M. Human pregnancy serum inhibits interleukin-2 production. Clin Exp Immunol. 1984 Dec;58(3):587–595. [PMC free article] [PubMed] [Google Scholar]
  21. Nékám K., Fudenberg H. H., Mándi B., Láng I., Gergely P., Petrányi G. Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: comparison of the effects of immunopotentiators of biological and synthetic origin in vitro. Immunopharmacology. 1981 Feb;3(1):31–39. doi: 10.1016/0162-3109(81)90036-9. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES